Αποτελέσματα αναζήτησης - Stockerl‐Goldstein, Keith
- Εμφανίζονται 1 - 20 Αποτελέσματα από 61
- Μετάβαση στην Επόμενη Σελίδα
-
1
-
2
-
3
-
4
-
5
Retrospective comparison of allogeneic versus autologous transplantation for diffuse large B cell lymphoma with early relapse or primary induction failure από Ghobadi, Armin, Nolley, Eric, Liu, Jingxia, McBride, Ali, Stockerl-Goldstein, Keith, Cashen, Amanda
Έκδοση 2014Κείμενο -
6
GENESIS: Phase III trial evaluating BL-8040 + G-CSF to mobilize hematopoietic cells for autologous transplant in myeloma από Crees, Zachary D, Stockerl-Goldstein, Keith, Vainstein, Abi, Chen, Hemda, DiPersio, John F
Έκδοση 2019Κείμενο -
7
-
8
A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome από Wu, Peggy A., Kim, Youn H., Lavori, Phillip W., Hoppe, Richard T., Stockerl-Goldstein, Keith E.
Έκδοση 2009Κείμενο -
9
Secondary Acute Lymphoblastic Leukemia, a retrospective analysis from Washington University and meta-analysis of published data. από Ferraro, Francesca, Gao, Feng, Stockerl-Goldstein, Keith, Westervelt, Peter, DiPersio, John F., Ghobadi, Armin
Έκδοση 2018Κείμενο -
10
Socioeconomic Status is Independently Associated with Overall Survival in Patients with Multiple Myeloma από Fiala, Mark A., Finney, Joseph D., Liu, Jingxia, Stockerl-Goldstein, Keith E., Tomasson, Michael H., Vij, Ravi, Wildes, Tanya M.
Έκδοση 2015Κείμενο -
11
-
12
High dose therapy and autologous stem cell transplant in older adults with multiple myeloma από Wildes, Tanya M, Finney, Joseph D, Fiala, Mark, Gao, Feng, Vij, Ravi, Stockerl-Goldstein, Keith, Carson, Kenneth R, Mikhael, Joseph, Colditz, Graham
Έκδοση 2015Κείμενο -
13
An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment από Dimopoulos, Meletios A., Mikhael, Joseph, Terpos, Evangelos, Leleu, Xavier, Moreau, Philippe, Bladé, Joan, Kim, Jin Seok, Stockerl-Goldstein, Keith, Richardson, Paul G.
Έκδοση 2022Κείμενο -
14
Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML από Ramsingh, Giridharan, Westervelt, Peter, McBride, Ali, Stockerl-Goldstein, Keith, Vij, Ravi, Uy, Geoffrey, Cashen, Amanda, DiPersio, John F., Abboud, Camille N.
Έκδοση 2014Κείμενο -
15
A Phase I Study of the Safety and Feasibility of Bortezomib in Combination with G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma από Ghobadi, Armin, Fiala, Mark A, Rettig, Michael, Schroeder, Mark, Uy, Geoffrey L., Stockerl-Goldstein, Keith, Westervelt, Peter, Vij, Ravi, DiPersio, John F
Έκδοση 2019Κείμενο -
16
The Effect of Donor Type on Outcomes in Adults with Acute Myeloid Leukemia after Reduced Intensity Hematopoietic Peripheral Blood Cell Transplant από Rashid, Nahid, Slade, Michael, Abboud, Ramzi, Gao, Feng, DiPersio, John F., Westervelt, Peter, Uy, Geoffrey, Stockerl-Goldstein, Keith, Romee, Rizwan, Schroeder, Mark A.
Έκδοση 2020Κείμενο -
17
Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor από Fadini, Gian Paolo, Fiala, Mark, Cappellari, Roberta, Danna, Marianna, Park, Soo, Poncina, Nicol, Menegazzo, Lisa, Albiero, Mattia, DiPersio, John, Stockerl-Goldstein, Keith, Avogaro, Angelo
Έκδοση 2015Κείμενο -
18
Fresh or Cryopreserved CD34(+)-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function following Allogeneic Hematopoietic Cell Transp... από Ghobadi, Armin, Fiala, Mark A., Ramsingh, Giridharan, Gao, Feng, Abboud, Camille N., Stockerl-Goldstein, Keith, Uy, Geoffrey L., Grossman, Brenda J., Westervelt, Peter, DiPersio, John F.
Έκδοση 2017Κείμενο -
19
Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study από Jagannath, Sundar, Laubach, Jacob, Wong, Ellice, Stockerl‐Goldstein, Keith, Rosenbaum, Cara, Dhodapkar, Madhav, Jou, Ying‐Ming, Lynch, Mark, Robbins, Michael, Shelat, Suresh, Anderson, Kenneth C., Richardson, Paul G.
Έκδοση 2018Κείμενο -
20
A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma από Schroeder, Mark A., Fiala, Mark A., Huselton, Eric, Cardone, Michael H., Jaeger, Savina, Jean, Sae Rin, Shea, Kathryn, Ghobadi, Armin, Wildes, Tanya M., Stockerl-Goldstein, Keith E., Vij, Ravi
Έκδοση 2019Κείμενο